Xcout Intel
On Target Laboratories competitors & alternatives
The 12 closest competitors and alternatives to On Target Laboratories among biotechnology companies — ranked by similarity to what On Target Laboratories actually does, not by market-cap band.
Subscribe to see On Target Laboratories’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About On Target Laboratories
On Target Laboratories, Inc. is a biotechnology company founded in 2010 and headquartered in West Lafayette, Indiana. It discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery.
On Target Laboratories at a glance
On Target Laboratories is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $44M in March 2018. Xcout tracks 12 named people at On Target Laboratories, including Bill Peters (President, Chief Executive Officer, and Board Member).
On Target Laboratories leadership
- Bill PetersPresident, Chief Executive Officer, and Board Member
- Rod MacLeodChief Financial Officer
- Tommy LeeSenior Vice President of Clinical Operations
- Anne FornicolaVice President of Chemistry, Manufacturing and Controls
- Catherine BrissonVice President of Regulatory Affairs and Quality
- Philip MacdonaldVice President of Market Access, Reimbursement and Health Economics
6 more named people on record for On Target Laboratories, with roles, board committees and tenure — see the full roster →
On Target Laboratories funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $44M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 On Target Laboratories competitors
Ranked by semantic similarity — how close each company is to On Target Laboratories by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Diagnostics
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
Health Care
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
Similar biotechnology company
MorphImmune Inc. is a biotechnology company focused on developing targeted oncology therapeutics. The company has corporate locations in Bothell, Washington, and West Lafayette, Indiana, and announced a definitive merger with Immunome.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Similar biotechnology company
ONL Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in Michigan, United States, focused on the development of novel therapies for retinal diseases.
Similar biotechnology company
Apexian Pharmaceuticals, Inc. is a clinical-stage research company based in Indianapolis, Indiana, dedicated to developing novel targeted therapeutics for oncology.
Biotech
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Biotech
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Similar biotechnology company
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Similar biotechnology company
NERx Biosciences, Inc. is a small business enterprise headquartered in Indianapolis, Indiana, dedicated to the discovery and development of targeted therapeutics for cancer.
Life Sciences
Alzeca Biosciences is a biotechnology company developing molecular imaging agents, including contrast agents intended to improve the detection and characterization of diseases such as Alzheimer’s disease and cancer. Its technologies are aimed at clinical researchers, physicians, and pharmaceutical or diagnostic development partners.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of On Target Laboratories and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for On Target Laboratoriesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →